2008 年至 2012 年中国北京地区大环内酯类耐药肺炎支原体的监测。
Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.
机构信息
National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
出版信息
Antimicrob Agents Chemother. 2013 Mar;57(3):1521-3. doi: 10.1128/AAC.02060-12. Epub 2012 Dec 21.
Abstract
Macrolide resistance rates of Mycoplasma pneumoniae in the Beijing population were as high as 68.9%, 90.0%, 98.4%, 95.4%, and 97.0% in the years 2008 to 2012, respectively. Common macrolide-resistant mobile genetic elements were not detected with any isolate. These macrolide-resistant isolates came from multiple clones rather than the same clone. No massive aggregation of a particular clone was found in a specific period.
摘要
2008 年至 2012 年，北京地区肺炎支原体大环内酯类耐药率分别高达 68.9%、90.0%、98.4%、95.4%和 97.0%。未检测到任何分离株携带常见的大环内酯类耐药移动遗传元件。这些耐药分离株来自多个克隆体，而非同一个克隆体。在特定时期，未发现特定克隆体的大规模聚集。
相似文献
1
Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.
Antimicrob Agents Chemother. 2013 Mar;57(3):1521-3. doi: 10.1128/AAC.02060-12. Epub 2012 Dec 21.
2
Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.
Antimicrob Agents Chemother. 2012 Feb;56(2):1108-9. doi: 10.1128/AAC.05627-11. Epub 2011 Nov 21.
3
Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.
Antimicrob Agents Chemother. 2009 May;53(5):2158-9. doi: 10.1128/AAC.01563-08. Epub 2009 Mar 9.
4
[Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Dec;36(12):954-8.
5
Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.
Emerg Infect Dis. 2013 Aug;19(8):1281-4. doi: 10.3201/eid1908.121455.
6
Antimicrobial susceptibility and genotyping of isolates in Beijing, China, from 2014 to 2016.
Antimicrob Resist Infect Control. 2019 Jan 24;8:18. doi: 10.1186/s13756-019-0469-7. eCollection 2019.
7
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Emerg Infect Dis. 2017 Oct;23(10):1703-1706. doi: 10.3201/eid2310.170106.
8
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Antimicrob Agents Chemother. 2009 May;53(5):2160-2. doi: 10.1128/AAC.01684-08. Epub 2009 Mar 9.
9
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.
10
Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Hong Kong Med J. 2011 Oct;17(5):407-9.
引用本文的文献
1
Clinical features and risk factors for severe macrolide-resistant mycoplasma pneumoniae pneumonia induced by 23 S rRNA A2063G mutation: a retrospective observational study.
Eur J Clin Microbiol Infect Dis. 2025 Jul 17. doi: 10.1007/s10096-025-05215-4.
2
Epidemiological changes of among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024.
Microbiol Spectr. 2025 Jul;13(7):e0312124. doi: 10.1128/spectrum.03121-24. Epub 2025 Jun 9.
3
Recent Macrolide Resistance Pattern of Mycoplasma Pneumonia in the World: A Systematic Review and Meta-Analysis.
Iran J Public Health. 2025 Mar;54(3):530-541. doi: 10.18502/ijph.v54i3.18246.
4
Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia.
Sci Rep. 2025 Apr 28;15(1):14860. doi: 10.1038/s41598-025-99537-0.
5
Characterizing the epidemiology of infections in China in 2022-2024: a nationwide cross-sectional study of over 1.6 million cases.
Emerg Microbes Infect. 2025 Dec;14(1):2482703. doi: 10.1080/22221751.2025.2482703. Epub 2025 Apr 6.
6
Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China.
Front Cell Infect Microbiol. 2024 Aug 16;14:1424554. doi: 10.3389/fcimb.2024.1424554. eCollection 2024.
7
Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
World J Pediatr. 2024 Sep;20(9):901-914. doi: 10.1007/s12519-024-00831-0. Epub 2024 Aug 14.
8
A study on viruses and bacteria with particular interest on Mycoplasma pneumoniae in children with exacerbation of asthma from a tertiary care hospital in Sri Lanka.
Access Microbiol. 2024 Jul 30;6(7). doi: 10.1099/acmi.0.000778.v5. eCollection 2024.
9
Structure-Based Virtual Screening, ADMET Properties Prediction and Molecular Dynamics Studies Reveal Potential Inhibitors of HPrK/P.
Life (Basel). 2024 May 22;14(6):657. doi: 10.3390/life14060657.
10
Effectiveness of the six-step approach guided online training program to improve knowledge of pneumonia among pediatricians: a pretest-posttest study.
Transl Pediatr. 2024 May 31;13(5):760-769. doi: 10.21037/tp-24-53. Epub 2024 May 24.
本文引用的文献
1
Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011.
J Clin Microbiol. 2013 Feb;51(2):636-9. doi: 10.1128/JCM.02567-12. Epub 2012 Dec 5.
2
Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.
Antimicrob Agents Chemother. 2012 Feb;56(2):1108-9. doi: 10.1128/AAC.05627-11. Epub 2011 Nov 21.
3
Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009.
J Clin Microbiol. 2011 Aug;49(8):3000-3. doi: 10.1128/JCM.00105-11. Epub 2011 Jun 22.
4
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.
Clin Infect Dis. 2010 Jul 15;51(2):189-94. doi: 10.1086/653535.
5
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.
Antimicrob Agents Chemother. 2010 Jun;54(6):2728-31. doi: 10.1128/AAC.01557-09. Epub 2010 Apr 12.
6
Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.
Clin Microbiol Infect. 2010 Jun;16(6):613-6. doi: 10.1111/j.1469-0691.2009.02968.x. Epub 2009 Sep 17.
7
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.
J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.
8
Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.
Antimicrob Agents Chemother. 2009 May;53(5):2158-9. doi: 10.1128/AAC.01563-08. Epub 2009 Mar 9.
9
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Antimicrob Agents Chemother. 2009 May;53(5):2160-2. doi: 10.1128/AAC.01684-08. Epub 2009 Mar 9.
10
New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.
Future Microbiol. 2008 Dec;3(6):635-48. doi: 10.2217/17460913.3.6.635.
Zotero 插件